Skip to content

55

55

NIDA-NIAAA Mini-Convention: Frontiers in Addiction Research, October 16Society for Neuroscience satellite meeting explores innovative.
See all stories on this topic

FDA requires boxed warnings for short-acting opioids

The Food and Drug Administration will require boxed warnings on the risks of abuse, misuse, addiction, overdose, and death for all immediate-release opioids. The decision is part of the latest wave of efforts by federal officials to combat the ballooning opioid epidemic. It comes a week after the Centers for Disease Control and Prevention issued guidelines recommending nonopioid analgesia for non
See all stories on this topic

[Affective mentalizing in Addictive Borderline Personality: A literature review].

We describe mentalization failure, its etiology and consequences in the BPD. Several forms of mentalization psychopathology are identified. Its etiology is largely environmental. Fonagy and Bateman developed the optimum developmental model of mentalization and referred to it to explain etiology of mentalization failure in BPD. Consequences of mentalization failure explicate its functioning. Mental
See all stories on this topic

FDA now requires ‘black box’ warning on painkillers

HTTP Error (Code) and Message: (404) Feed not found error: FeedBurner cannot locate this feed URI….
See all stories on this topic

New FDA Safety Warnings on Immediate-Release Opioids New FDA Safety Warnings on Immediate-Release Opioids

The agency has added a new boxed warning about the risks for misuse, abuse, addiction, overdose, and death and changes the indication to treatment of severe pain with no alternatives. News Alerts (Source: Medscape Neurology and Neurosurgery Headlines)
See all stories on this topic

Published inAddiction

Be First to Comment

Leave a Reply